Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Therapeutic Potential of Statins in Thyroid Proliferative Disease
Link ID 6256
Title Therapeutic Potential of Statins in Thyroid Proliferative Disease
Url http://www.medscape.com/viewarticle/573953?src=rss
Description Satins have been shown to exert pleiotropic effects on cell proliferation, survival, and migration, which suggests they could have chemopreventive properties. The author proposes that statins might have therapeutic potential in thyroid proliferative disease.
Nature Clinical Practice Endocrinology & Metabolism
Category Articles > Hematology-Oncology
Keywords
Date May 31, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Nurse Autonomy in Cancer Care
  Nurses are interviewed to mine their thoughts regarding workplace autonomy. Cancer Nursing
Category:   Articles > Hematology-Oncology


2. Circulating Endothelial Cells and Endothelial Progenitors as Predictive Markers of Clinical Response
  Can these biomarkers provide an early predictor of advanced CRC treatment success with bevacizumab? Annals of Oncology
Category:   Articles > Hematology-Oncology


3. Radiation Therapy-Induced Fatigue Linked to Inflammation
  Among patients with breast and prostate cancers, fatigue experienced during radiation therapy may be linked to activation of the proinflammatory cytokine network and its associated biomarkers. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. Combination Cetuximab-Chemotherapy Regimen Shows Survival Benefit in Patients with Advanced NSCLC
  Cetuximab combined with cisplatin/vinorelbine showed a small overall survival benefit in patients with advanced non-small-cell lung cancer over chemotherapy alone. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. Canada Revokes Bevacizumab for Breast Cancer, But Not EuropeCanada Revokes Bevacizumab for Breast Ca
  Canada has followed the United States in revoking the metastatic breast cancer indication for bevacizumab, but it remains in place in Europe. News Alerts
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS